Last reviewed · How we verify
NCT04411485
Sexual Dysfunction in Partner of Patients With Ankylosing Spondylitis
trial testing Sexual dysfunction in Ankylosing Spondylitis in 80 participants. Status unknown.
30 June 2020
Quick facts
| Lead sponsor | Antalya Training and Research Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 15 February 2018 |
| Primary completion | 30 June 2020 |
| Estimated completion | 15 July 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Sexual dysfunction
Conditions studied
- Ankylosing Spondylitis — all drugs for Ankylosing Spondylitis →
- Sexual Dysfunction — all drugs for Sexual Dysfunction →
Sponsor
Antalya Training and Research Hospital
Who can join
Adults 18 to 65, any sex, with Ankylosing Spondylitis or Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The adverse effects of rheumatologic diseases, especially Ankylosing Spondylitis (AS), on sexual functions are known. The causes of sexual dysfunction in rheumatologic diseases are due to factors such as pain, weakness, fatigue, stiffness, functional disability, anxiety, depression, hormonal deficiency, drug use, decreased libido and poor body image. Depending on these factors, sexual intercourse and frequency of sexual intercourse may decrease. Sexual dysfunction may be seen in AS due to physical and emotional problems caused by the disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04411485
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ankylosing Spondylitis
Currently open trials in the same condition.
- NCT07510789 — Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis · recruiting
- NCT07261644 — A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) · Phase 3 · recruiting
- NCT07390929 — Clinical Trial Study on the Improved New Method of Acupotomy for AS · NA · recruiting
- NCT06905288 — Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. · recruiting
- NCT07166874 — The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis · NA · recruiting
Other Antalya Training and Research Hospital trials
Trials by the same sponsor.
- NCT07480811 — The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD · NA · not yet recruiting
- NCT07453615 — Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children · NA · recruiting
- NCT07324655 — Association Between Office Ergonomics, Work Organization, and Musculoskeletal Complaints in Medical Secretaries · recruiting
- NCT07524933 — Comparison of the Effectiveness of Nerve Hydrodissection With Saline Injection of 5% Dextrose in Carpal Tunnel Syndrome. · NA · active not recruiting
- NCT07497295 — Ultrasound Assessment of Femoral Vein and Inferior Vena Cava Collapsibility to Predict Spinal Anesthesia-Induced Hypoten · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04411485 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Antalya Training and Research Hospital
- Last refreshed: 4 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04411485.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing